These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7771611)
21. The ultrastructural morphology of human cutaneous leishmaniasis of low parasite load. el Hassan AM; Veress B; Kutty MK Acta Derm Venereol; 1984; 64(6):501-5. PubMed ID: 6084921 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis. Saldanha MG; Queiroz A; Machado PRL; de Carvalho LP; Scott P; de Carvalho Filho EM; Arruda S Am J Trop Med Hyg; 2017 Mar; 96(3):645-652. PubMed ID: 28115669 [TBL] [Abstract][Full Text] [Related]
23. Cytologic features of "dry-type" cutaneous leishmaniasis. Dabiri S; Hayes MM; Meymandi SS; Basiri M; Soleimani F; Mousavi MR Diagn Cytopathol; 1998 Sep; 19(3):182-5. PubMed ID: 9740991 [TBL] [Abstract][Full Text] [Related]
24. Leishmaniasis in Sudan. Cutaneous leishmaniasis. el-Hassan AM; Zijlstra EE Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S1-17. PubMed ID: 11370248 [TBL] [Abstract][Full Text] [Related]
25. Matrix remodelling and fibroblast phenotype in early lesions of human cutaneous leishmaniasis. Esterre P; Dedet JP; Guerret S; Chevallier M; Frenay C; Grimaud JA Pathol Res Pract; 1991 Dec; 187(8):924-30. PubMed ID: 1792187 [TBL] [Abstract][Full Text] [Related]
26. Infectivity of macrophages and the histopathology of cutaneous lesions, liver and spleen is attenuated by leaf extract of Vernonia amygdalina in Leishmania major infected BALB/c mice. Alawa JN; Carter KC; Nok AJ; Kwanashie HO; Adebisi SS; Alawa CB; Clements CJ J Complement Integr Med; 2012 Jun; 9():Article 10. PubMed ID: 22713278 [TBL] [Abstract][Full Text] [Related]
27. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. Belkaid Y; Mendez S; Lira R; Kadambi N; Milon G; Sacks D J Immunol; 2000 Jul; 165(2):969-77. PubMed ID: 10878373 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Gaafar A; Veress B; Permin H; Kharazmi A; Theander TG; el Hassan AM Clin Immunol; 1999 Jun; 91(3):314-20. PubMed ID: 10370377 [TBL] [Abstract][Full Text] [Related]
29. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis. Eissa MM; Amer EI; El Sawy SM Exp Parasitol; 2011 Aug; 128(4):382-90. PubMed ID: 21620834 [TBL] [Abstract][Full Text] [Related]
31. Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages. Maksouri H; Dang PM; Rodrigues V; Estaquier J; Riyad M; Akarid K Parasit Vectors; 2017 Oct; 10(1):506. PubMed ID: 29061164 [TBL] [Abstract][Full Text] [Related]
32. Necrotizing and suppurative lymphadenitis in Leishmania major infections. Gaafar A; Ismail A; el Kadaro AY; Hashim E; Khalil EA; el Hassan AM Trop Med Int Health; 1996 Apr; 1(2):243-50. PubMed ID: 8665392 [TBL] [Abstract][Full Text] [Related]
33. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis. Fritzsche C; Schleicher U; Bogdan C Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313 [TBL] [Abstract][Full Text] [Related]
34. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives. Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949 [TBL] [Abstract][Full Text] [Related]
35. Polymerase chain reaction for diagnosis of cutaneous leishmaniasis in histologically positive, suspicious and negative skin biopsies. Safaei A; Motazedian MH; Vasei M Dermatology; 2002; 205(1):18-24. PubMed ID: 12145429 [TBL] [Abstract][Full Text] [Related]
36. Proliferative changes of epidermal cells in lesions of cutaneous leishmaniasis. Mangoud AM; Sanad EM; Fouad MA; Morsy TA J Egypt Soc Parasitol; 2005 Dec; 35(3):761-72. PubMed ID: 16333886 [TBL] [Abstract][Full Text] [Related]
37. Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Elamin EM; Guerbouj S; Musa AM; Guizani I; Khalil EA; Mukhtar MM; Elkadaro AM; Mohamed HS; Ibrahim ME; Abdel Hamid MM; El Azhari M; El Hassan AM Trans R Soc Trop Med Hyg; 2005 Nov; 99(11):803-8. PubMed ID: 16099005 [TBL] [Abstract][Full Text] [Related]
38. Western blot analysis as an aid for the diagnosis of cutaneous leishmaniasis due to Leishmania major. Pomares C; Despierres L; del Giudice P; Delaunay P; Michel G; Ferrua B; Marty P Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):452-4. PubMed ID: 22657532 [TBL] [Abstract][Full Text] [Related]
39. The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Ritter U; Mattner J; Rocha JS; Bogdan C; Körner H Microbes Infect; 2004 May; 6(6):559-65. PubMed ID: 15158189 [TBL] [Abstract][Full Text] [Related]
40. Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study. Ridley MJ; Wells CW Am J Pathol; 1986 Apr; 123(1):79-85. PubMed ID: 3963151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]